Davrion Labs

India Founded: 2020 • Age: 6 yrs
Marketing of pharmaceutical products, diet supplements, and active pharmaceutical ingredients in India.
Annual revenue $16,892 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Davrion Labs

Davrion Labs is a company based in India founded in 2020. The company has 1 employees as of April 08, 2024. Davrion Labs offers products and services including Thicomole and Tafobact-C.

  • Headquarter India
  • Employees 1 as on 08 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Davrion Labs Private Limited
  • Date of Incorporation 06 Nov, 2020
  • Jurisdiction Mira Road, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $16.89 K (USD)
    22.26
    as on Mar 31, 2023
  • Net Profit
    -$2.42 K (USD)
    42.74
    as on Mar 31, 2023
  • EBITDA
    -$2.33 K (USD)
    44.23
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Apr 08, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Davrion Labs

Davrion Labs offers a comprehensive portfolio of products and services, including Thicomole and Tafobact-C.

Product name locked
Category locked
Primary

Thicomole is marketed as a pharmaceutical product that is intended for sale in pharmacies.

Product name locked
Category locked
Locked

Tafobact-C is offered as a specialty medicine product that is based on its performance in healthcare applications.

Funding Insights of Davrion Labs

Premium access

Detailed funding history for Davrion Labs

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Davrion Labs

Investments
Premium access

Investment portfolio details for Davrion Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Davrion Labs

Premium access

Detailed financials for Davrion Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Davrion Labs Comparisons

Davrion Labs Primary company
Description
Marketing of pharmaceutical products, diet supplements, and ...
Location
India
Founded Year
2020
Annual Revenue
$16.89 K (USD)
Net Profit
-$2.42 K (USD)
EBITDA
-$2.33 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Davrion Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Davrion Labs

Premium access

Detailed competitors of Davrion Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Davrion Labs

Premium access

Complete news archive for Davrion Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Davrion Labs

Davrion Labs was founded in 2020.

Davrion Labs is headquartered in India.

As of Apr 08, 2024, the latest employee count at Davrion Labs is 1.

Annual revenue of Davrion Labs is $16.89K as on Mar 31, 2023.

Davrion Labs is identified as an Indian company in the healthcare medicine sector, where pharmaceutical products and diet supplements are marketed exclusively for pharmacy sales. Quality and innovative products are provided by the company, with emphasis placed on high-quality standards, exceptional customer service, and technical expertise in areas like active pharmaceutical ingredients. Testimonials indicate that total medicine solutions are delivered that meet expectations, and the company operates from its registered office in Thane, India, as a trusted marketer and distributor.

Davrion Labs offers Thicomole and Tafobact-C.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available